Last reviewed · How we verify
Non-Vitamin K Oral Antagonists — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Non-Vitamin K Oral Antagonists (Non-Vitamin K Oral Antagonists) — Abbott Medical Devices.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Non-Vitamin K Oral Antagonists TARGET | Non-Vitamin K Oral Antagonists | Abbott Medical Devices | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Non-Vitamin K Oral Antagonists CI watch — RSS
- Non-Vitamin K Oral Antagonists CI watch — Atom
- Non-Vitamin K Oral Antagonists CI watch — JSON
- Non-Vitamin K Oral Antagonists alone — RSS
Cite this brief
Drug Landscape (2026). Non-Vitamin K Oral Antagonists — Competitive Intelligence Brief. https://druglandscape.com/ci/non-vitamin-k-oral-antagonists. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab